Monitoring respiratory disease severity in cystic fibrosis

Respiratory Care

Volumn 54, Issue 5, 2009, Pages 606-615

  Davies, Jane C ^a,b   Alton, Eric W F W ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; Monitoring

Indexed keywords

ANTIBIOTIC AGENT;

CLINICAL ASSESSMENT; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; LUNG BLOOD FLOW; LUNG CLEARANCE; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG INFECTION; LUNG LAVAGE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLETHYSMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RESPIRATORY TRACT MUCOSA; SENSITIVITY AND SPECIFICITY; SPIROMETRY; SPUTUM ANALYSIS;

CYSTIC FIBROSIS; DIAGNOSTIC IMAGING; HUMANS; MONITORING, PHYSIOLOGIC; PLETHYSMOGRAPHY; RESPIRATORY PHYSIOLOGICAL PHENOMENA; SPIROMETRY;

EID: 66849138757     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: 10.4187/aarc0493     Document Type: Conference Paper

References (53)

1. Cystic Fibrosis Trust. Standards for the clinical care of children and adults with cystic fibrosis in the UK 2001: a revised, expanded and referenced version of the Cystic Fibrosis Trust's 1996 guidelines. May 2001. http://www.cftrust.org.uk/aboutcf/publications/consensusdoc/c-3000standards-of- care.pdf. Accessed March 18, 2009.
2. Kerem E, Conway S, Elborn S, Heijerman H; Consensus Committee. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005;4(1):7-26. (Pubitemid 40347773)
3. Cotes JE, Leathart GL Lung function, physiology, measurement and application in medicine, 6th edition. Blackwell Science; 1993.
4. Cooper PJ, Robertson CF, Hudson IL, Phelan PD. Variability of pulmonary function tests in cystic fibrosis. Pediatr Pulmonol 1990;8(1):16-22.
5. Que C, Cullinan P, Geddes D. Improving rate of decline of FEV1 in young adults with cystic fibrosis. Thorax 2006;61(2):155-157. (Pubitemid 43235433)
6. Davis SQ, Garrity ER Jr. Organ allocation in lung transplant. Chest 2007;132(5):1646-1651. (Pubitemid 350156024)
7. Rosenthal M. Annual assessment spirometry, plethysmography, and gas transfer in cystic fibrosis: do they predict death or transplantation. Pediatr Pulmonol 2008;43(10):945-952.
8. Aurora P, Gustafsson P, Bush A, Lindblad A, Oliver C, Wallis CE, Stocks J. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax 2004;59(12):1068-1073. (Pubitemid 39573927)
9. Aurora P, Bush A, Gustafsson P, Oliver C, Wallis C, Price J, et al; London Cystic Fibrosis Collaboration. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005;171(3):249-256.
10. Lum S, Gustafsson P, Ljungberg H, Hülskamp G, Bush A, Carr SB, et al; London Cystic Fibrosis Collaboration. Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests. Thorax 2007;62(4):341-347.
11. Horsley AR, Gustafsson PM, Macleod KA, Saunders C, Greening AP, Porteous DJ, et al. Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax 2008;63(2):135-140. (Pubitemid 351236478)
12. Kraemer R, Blum A, Schibler A, Ammann RA, Gallati S. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005;171(4):371-378. (Pubitemid 40223405)
13. Gustafsson PM, De Jong PA, Tiddens HA, Lindblad A. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 2008;63(2):129-134. (Pubitemid 351236476)
14. Beydon N, Davis SD, Lombardi E, Allen JL, Arets HG, Aurora P, et al. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 2007;175(12):1304-1345. (Pubitemid 46905757)
15. Ranganathan SC, Stocks J, Dezateux C, Bush A, Wade A, Carr S, et al. The evolution of airway function in early childhood following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2004;169(8):928-933. (Pubitemid 38457319)
16. Linnane BM, Hall GL, Nolan G, Brennan S, Stick SM, Sly PD, et al.; on behalf of the Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST-CF). Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med 2008;178(12):1238-1244.
17. Kozlowska WJ, Bush A, Wade A, Aurora P, Carr SB, Castle RA, et al.; London Cystic Fibrosis Collaboration. Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2008;178(1):42-49.
18. Davies JC, Bilton D. Bugs, biofilms, and resistance in cystic fibrosis. Respir Care 2009;54(5):628-638; discussion 638-640.
19. Wood DM, Smyth AR. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst Rev 2006;(1):CD004197.
20. Festini F, Buzzetti R, Bassi C, Braggion C, Salvatore D, Taccetti G, Mastella G. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review. J Hosp Infect 2006;64(1):1-6. (Pubitemid 44161372)
21. Equi AC, Pike SE, Davies J, Bush A. Use of cough swabs in a cystic fibrosis clinic. Arch Dis Child 2001;85(5):438-439. (Pubitemid 33702304)
22. Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999;28(5):321-328. (Pubitemid 29523443)
23. Gutierrez JP, Grimwood K, Armstrong DS, Carlin JB, Carzino R, Olinsky A, et al. Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis. Eur Respir J 2001;17(2):281-286. (Pubitemid 32600589)
24. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Kehagia V, et al. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J Clin Microbiol 2006;44(7):2601-2604. (Pubitemid 44092439)
25. Carroll W, Lenney W, Wang T, Spanel P, Alcock A, Smith D. Detection of volatile compounds emitted by Pseudomonas aeruginosa using selected ion flow tube mass spectrometry. Pediatr Pulmonol 2005;39(5):452-456.
26. Ryall B, Davies JC, Wilson R, Shoemark A, Williams HD. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients. Eur Respir J 2008;32(3):740-747.
27. Moskowitz SM, Foster JM, Emerson JC, Gibson RL, Burns JL. Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection. J Antimicrob Chemother 2005;56(5):879-886.
28. Caraher E, Reynolds G, Murphy P, McClean S, Callaghan M. Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro. Eur J Clin Microbiol Infect Dis 2007;26(3):213-216.
29. Ordonez CL, Kartashov AI, Wohl ME. Variability of markers of inflammation and infection in induced sputum in children with cystic fibrosis. J Pediatr 2004;145(5):689-692. (Pubitemid 39440951)
30. Colombo C, Costantini D, Rocchi A, Cariani L, Garlaschi ML, Tirelli S, et al. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy. Pediatr Pulmonol 2005;40(1):15-21. (Pubitemid 40917903)
31. Ordonez CL, Henig NR, Mayer-Hamblett N, Accurso FJ, Burns JL, Chmiel JF, et al. Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis. Am J Respir Crit Care Med 2003;168(12):1471-1475. (Pubitemid 38037331)
32. Ledson M, Gallagher M, Hart CA, Walshaw M. Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients. Eur Respir J 2001;17(1):36-38.
33. Suri R, Marshall LJ, Wallis C, Metcalfe C, Shute JK, Bush A. Safety and use of sputum induction in children with cystic fibrosis. Pediatr Pulmonol 2003;35(4):309-313. (Pubitemid 36397684)
34. Kim JS, Hackley GH, Okamoto K, Rubin BK. Sputum processing for evaluation of inflammatory mediators. Pediatr Pulmonol 2001;32(2):152-158. (Pubitemid 32730253)
35. Wainwright CE, Grimwood K, Carlin JB, Vidmar S, Cooper PJ, Francis PW, et al. Safety of bronchoalveolar lavage in young children with cystic fibrosis. Pediatr Pulmonol 2008;43(10):965-972.
36. Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 1999;14(2):245-248. (Pubitemid 29461283)
37. Moeller A, Horak F Jr, Lane C, Knight D, Kicic A, Brennan S, et al. Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis. Thorax 2006;61(6):514-520. (Pubitemid 43901522)
38. Grasemann H, Grasemann C, Kurtz F, Tietze-Schillings G, Vester U, Ratjen F. Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study. Eur Respir J 2005;25(1):62-68. (Pubitemid 40207732)
39. Tate S, MacGregor G, Davis M, Innes JA, Greening AP. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 2002;57(11):926-929. (Pubitemid 35316268)
40. Carpagnano GE, Barnes PJ, Francis J, Wilson N, Bush A, Kharitonov SA. Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation? Chest 2004;125(6):2005-2010.
41. Ojoo JC, Mulrennan SA, Kastelik JA, Morice AH, Redington AE. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax 2005;60(1):22-26. (Pubitemid 40101013)
42. Carpagnano GE, Barnes PJ, Geddes DM, Hodson ME, Kharitonov SA. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med 2003;167(8):1109-1112. (Pubitemid 36459657)
43. Rosias PP, Dompeling E, Hendriks HJ, Heijnens JW, Donckerwolcke RA, Jobsis Q. Exhaled breath condensate in children: pearls and pitfalls. Pediatr Allergy Immunol 2004;15(1):4-19. (Pubitemid 38327294)
44. Wanner A, Mendes ES, Atkins ND. A simplified noninvasive method to measure airway blood flow in humans. J Appl Physiol 2006;100(5):1674-1678.
45. Bode DC, Pagani ED, Cumiskey WR, von Roemeling R, Hamel L, Silver PJ. Comparison of urinary desmosine excretion in patients with chronic obstructive pulmonary disease or cystic fibrosis. Pulm Pharmacol Ther 2000;13(4):175-180.
46. Robinson TE. High-resolution CT scanning: potential outcome measure. Curr Opin Pulm Med 2004;10(6):537-541. (Pubitemid 39441450)
47. Brody AS. Scoring systems for CT in cystic fibrosis: who cares? Radiology 2004;231(2):296-298.
48. Robinson TE, Leung AN, Northway WH, Blankenberg FG, Chan FP, Bloch DA, et al. Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease. Am J Respir Crit Care Med 2003;168(5):588-593. (Pubitemid 37088603)
49. Huda W. Radiation doses and risks in chest computed tomography examinations. Proc Am Thorac Soc 2007;4(4):316-320. (Pubitemid 47330863)
50. Long FR. High-resolution computed tomography of the lung in children with cystic fibrosis: technical factors. Proc Am Thorac Soc 2007;4(4):306-309. (Pubitemid 47330861)
51. Mentore K, Froh DK, de Lange EE, Brookeman JR, Paget-Brown AO, Altes TA. Hyperpolarized HHe 3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment. Acad Radiol 2005;12(11):1423-1429. (Pubitemid 41512835)
52. Chen DL, Ferkol TW, Mintun MA, Pittman JE, Rosenbluth DB, Schuster DP. Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am J Respir Crit Care Med 2006;173(12):1363-1369. (Pubitemid 43900711)
53. UK Cystic Fibrosis Gene Therapy Consortium. Current research. http://www.cfgenetherapy.org.uk/consortiumresearch.htm. Accessed March 18, 2009.